Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-09-19

Clinical Trial Update: Quantitative and Repetitive TMS in ALS - Recruiting for Stage 2 [NA]

View source ↗

Summary

Stage 2 recruitment is ongoing for a study using quantitative and repetitive transcranial magnetic stimulation in amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcranial Magnetic Stimulation (TMS)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: RECRUITING